Pro-Life Groups Decry DOJ Move on Abortion Drug Lawsuit
The Trump administration’s court filing in the Louisiana abortion pill case has intensified tensions with pro-life allies.
WASHINGTON, D.C. — The Trump administration has urged a federal court to temporarily deny relief to Louisiana in its lawsuit challenging Biden-era rules that allow abortion pills to be dispensed by mail, a move that has angered pro-life advocates only days after the administration voiced support at the March for Life.
Louisiana, joined by plaintiff Rosalie Markezich, sued the U.S. Food and Drug Administration over its removal of in-person dispensing requirements for mifepristone, arguing the change violates state law and endangers women. State officials say mail-order abortion drugs undermine enforcement of Louisiana’s abortion restrictions and contribute to medical emergencies.
On Tuesday, the Trump FDA asked the court to pause the case, arguing the plaintiffs lack standing and that judicial intervention would disrupt the agency’s ongoing review of abortion-pill safety rules. Pro-life groups, including Susan B. Anthony Pro-Life America, sharply criticized the filing, accusing the administration of delaying safeguards while maintaining Biden-era policies.
Previously, the UOJ reported that Missouri sued Planned Parenthood over deception on abortion-pill safety.
